HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

V De Stefano Selected Research

Prothrombin (Factor II)

12/2016Review article: the aetiology of primary Budd-Chiari syndrome - differences between the West and China.
12/2010Effect of prothrombin 19911 A>G polymorphism on the risk of cerebral sinus-venous thrombosis.
3/2008The risk of first venous thromboembolism during pregnancy and puerperium in double heterozygotes for factor V Leiden and prothrombin G20210A.
11/2007The G20210A prothrombin variant and the risk of venous thromboembolism or fetal loss in pregnant women: a family study.
1/2004G20210A prothrombin gene polymorphism and coronary ischaemic syndromes: a phenotype-specific meta-analysis of 12 034 subjects.
1/2002Increased prevalence of the G20210A prothrombin gene variant in acute coronary syndromes without metabolic or acquired risk factors or with limited extent of disease.
9/2001Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
9/2001Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
6/2001The risk of recurrent venous thromboembolism among heterozygous carriers of the G20210A prothrombin gene mutation.
3/2001G20210A prothrombin gene mutation and other trombophilic polymorphisms in patients with portal or hepatic venous thrombosis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


V De Stefano Research Topics

Disease

10Venous Thromboembolism
10/2017 - 01/2000
7Thrombosis (Thrombus)
08/2014 - 01/2000
7Thrombophilia
12/2010 - 07/2000
6Venous Thrombosis (Deep-Vein Thrombosis)
10/2017 - 03/2001
4Multiple Myeloma
04/2021 - 05/2000
4Thromboembolism
08/2014 - 06/2001
3Pulmonary Embolism
10/2017 - 06/2001
3Neoplasms (Cancer)
12/2016 - 04/2013
3Myocardial Infarction
12/2006 - 01/2002
3Acute Coronary Syndrome
05/2004 - 07/2001
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
09/2001 - 07/2000
2Protein S Deficiency (Deficiency, Protein S)
12/2016 - 06/2001
2Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
12/2016 - 06/2001
2Hypersensitivity (Allergy)
06/2015 - 01/2015
2Leukemia
04/2013 - 09/2005
2Hemorrhage
04/2005 - 09/2002
2Coronary Disease (Coronary Heart Disease)
01/2002 - 07/2000
2Hyperhomocysteinemia
09/2001 - 01/2000
1Type 2 Diabetes Mellitus (MODY)
10/2017
1Bacterial Infections (Bacterial Infection)
12/2016
1Thrombocytopenia (Thrombopenia)
06/2015
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
08/2014
1Intracranial Thrombosis (Cerebral Thrombosis)
12/2010
1Myeloproliferative Disorders (Myeloproliferative Disorder)
04/2007
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
09/2005
1Postpartum Hemorrhage
04/2005
1Congenital Abnormalities (Deformity)
03/2005
1Heart Diseases (Heart Disease)
01/2004
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2004
1Unstable Angina
01/2002
1Anemia
12/2001
1Hematologic Diseases (Blood Diseases)
12/2001
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
10/2001
1Pneumonia (Pneumonitis)
02/2001
1Budd-Chiari Syndrome (Budd Chiari Syndrome)
12/2000
1Ulcerative Colitis
07/2000
1Crohn Disease (Crohn's Disease)
07/2000
1Homocystinuria
01/2000
1Vascular System Injuries
01/2000

Drug/Important Bio-Agent (IBA)

15Prothrombin (Factor II)IBA
12/2016 - 01/2000
11factor V LeidenIBA
12/2016 - 01/2000
5AnticoagulantsIBA
10/2017 - 12/2000
3HomocysteineIBA
07/2009 - 01/2000
2Vitamin KFDA Link
10/2017 - 10/2016
2Protein CIBA
12/2016 - 06/2001
2ThrombinFDA Link
12/2016 - 06/2001
2Heparin (Liquaemin)FDA LinkGeneric
06/2015 - 01/2015
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
12/2006 - 05/2000
2Factor V (Coagulation Factor V)IBA
01/2002 - 12/2000
1Immunomodulating AgentsIBA
04/2021
1daratumumabIBA
04/2021
1fibrin fragment D (D-dimer)IBA
10/2017
1Glucose (Dextrose)FDA LinkGeneric
10/2017
1Oxidoreductases (Dehydrogenase)IBA
12/2016
15,10-methylenetetrahydrofolic acidIBA
12/2016
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
06/2015
1Pharmaceutical PreparationsIBA
06/2015
1Fondaparinux (Arixtra)FDA Link
01/2015
1SteroidsIBA
08/2014
1Inosine Triphosphate (ITP)IBA
08/2014
1Thrombopoietin (c-mpl Ligand)IBA
08/2014
1Diphosphonates (Bisphosphonates)IBA
05/2012
1poly(dG-dA)n.poly(dC-dT)n (((GA)n))IBA
12/2010
1Janus Kinase 2IBA
04/2007
1Asparaginase (Elspar)FDA Link
09/2005
1Glycoproteins (Glycoprotein)IBA
05/2004
1Norgestrel (DL-Norgestrel)FDA LinkGeneric
09/2002
1Octreotide (Sandostatin)FDA LinkGeneric
09/2002
1ProgesteroneFDA LinkGeneric
09/2002
1Norethindrone (Norethisterone)FDA LinkGeneric
09/2002
1Phospholipids (Phosphatides)FDA LinkGeneric
12/2001
1Alkaline PhosphataseIBA
12/2001
1EpitopesIBA
12/2001
1Pancreatic Elastase (Elastase)IBA
12/2001
1PhosphatidylserinesIBA
12/2001
1Proteins (Proteins, Gene)FDA Link
12/2001
1Thromboplastin (Tissue Factor)IBA
12/2001
1ThromboxanesIBA
12/2001
1GemcitabineFDA Link
10/2001
1EnzymesIBA
09/2001
1Folic Acid (Vitamin M)FDA LinkGeneric
09/2001
1VitaminsIBA
09/2001
1Integrin alpha2IBA
07/2001
1Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
02/2001
1Melphalan (Alkeran)FDA LinkGeneric
05/2000
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2000
1AntithrombinsIBA
04/2000
1Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
01/2000

Therapy/Procedure

3Therapeutics
10/2017 - 05/2012
1Aftercare (After-Treatment)
10/2017
1Duration of Therapy
10/2016
1Hysterectomy
04/2005
1Stem Cell Transplantation
02/2001
1Transplantation
02/2001
1Drug Therapy (Chemotherapy)
05/2000